Houston currently supports over 140 life science companies and is a place where biotechnology is continuing to grow and prosper. Employing around 75,000 life science workers, Houston as a leader in the industry comes as no surprise. Houston leads in 5 areas of research: Cardiovascular Medicine Genomics and bioinformatics Infectious diseases and biodefense Oncology… Read More »
Houston, Texas – A Biotech City
Cystic Fibrosis & Gene Therapy
Learn about Cystic Fibrosis The UK Cystic Fibrosis Gene Therapy Consortium Science Daily – Cystic Fibrosis Studies Largest Gene Therapy Trial for Cystic Fibrosis First FDA Approved Drug for Cystic Fibrosis Cystic Fibrosis Gene Therapy Program Gets Green Light with Public Funding Contact VGXI to learn more about our plasmid manufacturing capabilities or to request a… Read More »
cGMP Manufacturing – Why Comply?
“cGMPs” or “current good manufacturing practices” are guidelines that outline the aspects of production and testing that can impact the quality of a drug product. These general principles must be observed during drug product manufacturing. GMP guidelines include all aspects of production; from the starting materials, the facility, equipment, and training of personnel. Detailed, written… Read More »
What are DNA Vaccines?
DNA vaccines are third generation vaccines, made up of small, circular pieces of bacterial DNA, plasmids. These plasmids are genetically engineered to produce specific antigens from a pathogen. The DNA is injected into the cells of the body where the host cell then interprets the DNA and uses it to synthesize the pathogen’s proteins. An… Read More »
Microchip Vaccine Delivery – No Longer a Thing of the Future
A recent clinical trial performed by U.S. scientists proves that the “futuristic idea that microchips could be implanted under a patient’s skin to control the release of drugs has taken another step forward.” The Details The microchip, along with several (dependent on the number of doses needed) small, individually sealed wells of drug product, is packaged… Read More »
Breathing Easier – The First Cystic Fibrosis Drug is FDA Approved
Cystic Fibrosis In the U.S. around 30,000 patients suffer from cystic fibrosis, a genetic disorder that causes the body to produce an unusually thick and sticky mucus that clogs the lungs, obstructs the pancreas, and stops enzymes from helping the body break down and absorb food. Patients are also prone to infections and progressively lose… Read More »
2012 Conferences – Will You Be There?
VGXI will be attending several DNA Vaccine, Gene Therapy, and Biotechnology conferences in 2012 and we’d like to meet and get to know you. Here are the events we are attending: Phacilitate – Washington DC – This week Jan 30 – Feb 1 Cell & Gene Therapy Forum Washington Vaccine Forum Protein Therapeutics Forum… Read More »
A Texas Born Vaccine Targets Breast Cancer
Recently according to Defense.gov, military researchers have developed a vaccine that targets a protein commonly over-expressed in breast cancer cells called human epidermal growth factor receptor 2, or HER2/neu. This cancer vaccine known as E-75, a mix of the E-75 peptide of the HER2 protein and an immune system stimulant, is currently on its way… Read More »
What’s In-Store for Gene Therapy and Vaccines in 2012?
First, I’d like to take a moment on behalf of all of us at VGXI, Inc. to wish each one of you a Happy New Year. 2011 might be over but 2012 has a lot in-store in the health and biotechnology industries. From gene therapy clincial studies to anti-cancer vaccines, 2012 is off to a… Read More »
Why Should You Invest in DNA Vaccines?
According to Leah Johnson from Imassera News, investing in DNA Vaccines “holds great promise” and “if investors can be patient there can be millions made from investing early.The market is in such an early stage that it is expected to increase from just under $200 million in 2011 to more than $2.7 billion before the… Read More »
100% HIV Protection In Mice Using Gene Therapy
According to the recently released Nature Magazine article, “Gene Therapy Can Protect Against HIV” a team of biologists at California Institute of Technology in Pasadena, California have developed a new approach to HIV prevention. What? This new approach called Vectored ImmunoProphylaxis or VIP uses gene therapy an approach most commonly recognized for curing genetic diseases… Read More »
Attack of the Tryptophan
10 Facts about Tryptophan and why you should have that extra piece of turkey for your health’s sake: 1. Tryptophan is an essential amino acid, that can not be synthesized from the body and must be acquired from the diet. 2. Tryptophan is the precursor to 5-hydroxytrypophan (5-HTP) which is the direct precursor to… Read More »